$CVAC

CureVac N.V.

  • NASDAQ/NMS (GLOBAL MARKET)
  • Health Technology
  • Pharmaceuticals: Major

PRICE

$49.99 ▲1.482%

Extented Hours

VOLUME

752,087

DAY RANGE

48.92 - 51.795

52 WEEK

36.15 - 151.8

Join Discuss about CVAC with like-minded investors

profile
@DarkPoolAlgo #Dark Pool Charts
recently

$VLO, $BIDU, $BILI, $CVAC, $LMND, $MPC, $OZON, $PSX, $SGEN, $SRE, $TAP, $BEKE, $EQH, $KWEB, $LVS ,$ATHM BULLIISH for the Week

80 Replies 7 👍 10 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, July 1, 2021 Futures Up/Down % Last Dow 17.00 0.05% 34,416 S&P 500 0.50 0.01% 4,289 Nasdaq -29.50 0.20% 14,519 Stocks are muted to begin the second half of the year ahead of an OPEC+ meeting and weekly jobless claims data today and the monthly non-farm payrolls jobs report tomorrow morning. The Nasdaq is slipping in pre-market trading, continuing yesterday’s underperformance. Micron shares are also trading down in the pre-market despite its earnings beat and guidance raise after the company raised its capex guidance due to higher input costs and investments in new products. Bitcoin is sliding again over the past 2 days, as it is now valued at about $33,300 despite being above $36,000 on Tuesday afternoon. WTI Crude has also hit $75/barrel for the first time since October 2018 after reports that OPEC+ has reached a preliminary output deal. In Asian markets, The Nikkei Index is off by 84 points, the Shanghai Index has barely budged down 2 points, and the Hang Seng Index is down 166 points. In Europe, the German DAX has edged higher by 19 points, while the FTSE 100 has gained 42 points. Market Closing Prices Yesterday The S&P 500 Index rose 5.52 points, or 0.13%, to 4,297 The Dow Jones Industrial Average climbed 210.29 points, or 0.61%, to 34,502 The Nasdaq Composite dipped -24.38 points, or 0.17%, to 14,504 The Russell 2000 Index inched higher 1.71 points, or 0.07% to 2,310 Economic Calendar: 7:30 AM ET Challenger Layoffs for June 8:30 AM ET Weekly Jobless Claims 8:30 AM ET Continuing Claims 9:45 AM ET Markit Manufacturing PM, June-F 10:00 AM ET Construction Spending for May 10:00 AM ET ISM Manufacturing PMI, for June 10:30 AM ET Weekly EIA Natural Gas Inventory Data Earnings Calendar: Earnings Before the Open: $AYI, $LNN, $MKC, $SMPL, $WBA Earnings After the Close: None Other Key Events: Raymond James Company Meetings at Mobile World Congress (virtual), 6/28-7/1 Macro Up/Down Last Nymex 1.32 75.94 Brent 1.52 74.99 Gold 3.05 1,774 EUR/USD 0.0001 1.1856 JPY/USD 0.47 111.58 10-Year Note +0.031 1.475% Sector News Breakdown Consumer Hertz ($HTZZ) common stock to trade as $HTZZ (from HTZGQ) starting today after emerging from Chapter 11 bankruptcy Bally’s ($BALY) and Gamesys Group shareholders both approved the companies’ proposed business combination McCormick & Co ($MCK) Q2 adj EPS $0.69 vs est $0.61; Q2 revenue $1.56B vs est $1.47B; sees FY21 adj EPS $3.00-$3.05 from prev. $2.97-$3.02; expects to FY21 sales growth 11-13%, 8-10% in constant currency, Energy, Industrials & Materials ExxonMobil ($XOM) sees Q2 earnings gain of $0.6-1B from higher oil price, $200M from higher gas prices, and $800M in chemical margins Apache ($APA) filed mixed securities shelf Enbridge ($ENB) upgraded to Neutral at Goldman Edison International ($EIX) downgraded to Sector Weight from OW at KeyBanc Desktop Metal ($DM) files to sell 2.49M shares of common stock for holders U.S. Department of Defense awarded new contracts to Lockheed Martin ($LMT), Raytheon ($RTX), Mercury Systems ($MRCY), Northrup Grumman ($NOC), L3Harris Technologies ($LHX) MKS Instruments ($MKSI) agreed to acquire Atotech ($ATC) for $5.1 billion in cash in stock, paying $16.20 in cash and 00052 of a share of MKS for each ATC common share. This deal is equivalent to $26.02/share, a 1.9% premium Financials Realty Income (O) started an offering of 7.3M shares Franklin Covey (FC) Q3 EPS $0.90 vs est $0.07, Q3 revenue $58.7M vs est $51.6M; now sees FY21 adj EBITDA $24.5M-$26.5M from prev. range $20M-$22M Healthcare Apellis ($APLS) and Beam Therapeutics ($BEAM) entered into an exclusive research collaboration to apply base editing to discover novel therapies for complement-driven diseases Raymond James initiated coverage on Passage Bio ($PASB) at Outperform with a $29 PT, Agios Pharmaceuticals ($AGIO) at Market Perform, and Vertex Pharmaceuticals ($VRTX) at Market Perform CureVac ($CVAC) said statistical criteria for primary endpoint were met – Phase 2b/3 showed protection in age group 18-60; 48% vaccine efficacy against Covid of any severity across all age groups and 15 variants, 53% against disease of any severity, and 77% against moderate and severe disease. Novavax ($NVAX) published results of its UK Phase 3 clinical trial that demonstrated high levels of efficacy of its Covid-19 vaccine Technology, Media & Telecom Micron ($MU) 3Q adj eps $1.88 vs est. $1.72, gross margin 42.9% vs est. 42.0%; sees 4Q revs $8-8.4B vs est. $7.85B; expects DRAM, NAND supply to remain tight into 2022 Texas Instruments ($TXN) announced it purchased Micron’s (MU) 300-mm semiconductor factory in Lehi, UT for $900M $COHU announced a $100 million debt prepayment that reduces outstanding principal of its term loan B facility to about $104M and is is expected to save about $0.8M in fiscal Q3 interest expense DBV Technologies ($DBVT) filed for stock shelf of up to $250M Shaw Communications ($SJR) Q3 EPS $0.56 vs est $0.28 on revs $1.1B (+18.2% YoY)

42 Replies 10 👍 7 🔥

XX
@xX_Drip_Gawd_Xx #StockTraders.NET
recently

$CVAC bad COVID vaccine results. Only 47% effective.

111 Replies 13 👍 12 🔥

profile
@dros #droscrew
recently

Upgrades 6/17: $ABEV $ACOR $ATUS $BK $BOOT $CHTR $CPA $ENB $IR $MC $NOAH $PDCO $T $VEON . Downgrades 6/17: $BNL $CNST $CONE $CVAC $CWH $HNST $KIN $LPL $MSGE $NTRS $OHI $THO $VOYA $WGO $WRE

45 Replies 8 👍 7 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

/*============================================= = Thursday, June 17, 2021 = =============================================*/ Futures Up/Down % Last Dow -110.00 0.32% 33,795 S&P 500 -16.25 0.39% 4,196 Nasdaq -87.50 0.63% 13,885 U.S. stock futures are lower, with major averages looking to open down between -0.3% and -0.6% after the Federal Reserve left interest rates unchanged on Wednesday but signaled it expected to boost interest rates two times by the end of 2023, earlier than Wall Street had anticipated. Treasury yields ended higher yesterday, as the 10-year holding around the 1.57% level (up roughly 8 bps prior to the Fed announcement). The number of Fed governors who expect rate hikes as early as 2022 – known as the dot plot – went to seven from four, essentially translating into two rate hikes in 2023 based on growth and inflation projections from the 18 members of the FOMC as the economy recovers rapidly from the effects of the pandemic and inflation heats up. Banking shares rally, however, as bond yields rise, with the 10-year Treasury hitting 1.55%. Chairman Jerome Powell also said officials discussed an eventual reduction of bond-buying, though the timing of such a move remains uncertain. In Asian markets, The Nikkei Index dropped -272 points to 29,018, the Shanghai Index rose 7 points to 3,525, and the Hang Seng Index gained 121 points to settle at 28,558. In Europe, the German DAX is down around -20 points to 5,695, while the FTSE 100is down -30 points at 7,150. Precious metal prices are plunging with gold and silver down sharply as the U.S. dollar rebounds. Market Closing Prices Yesterday The S&P 500 Index slipped -22.89 points, or 0.54%, to 4,223.70 The Dow Jones Industrial Average fell -265.63 points, or 0.77%, to 34,033.67 The Nasdaq Composite dipped -33.22 points, or 0.24%, to 14,039.68 The Russell 2000 Index declined -5.38 points, or 0.23% to 2,314.69 Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 359K 8:30 AM EST Continuing Claims…est. 3.43M 8:30 AM EST Philly Fed Business Index for June…est. 31.0 10:00 AM EST Leading Index MoM for May…est. 1.3% 10:30 AM ET Weekly EIA Natural Gas Inventory Data Earnings Calendar: Earnings Before the Open: $CMC, $JBL, $KR Earnings After the Close: $ADBE, $SWBI Other Key Events: Cowen Annual Future Health Conference (virtual), 6/16-6/17 Deutsche Bank Global Auto Industry Conference (virtual), 6/16-6/17 European Hematology Association (EHA) Virtual Meeting, 6/9-6/17 Macro Up/Down Last Nymex -0.07 72.08 Brent -0.10 74.29 Gold -10.10 1,801.35 EUR/USD -0.0063 1.1932 JPY/USD 0.05 110.76 10-Year Note -0.007 1.562% World News Brazil’s Central Bank raises rates by 75bps to 4.25% as expected; indicates it may do so again next meeting Swiss National Bank rates unchanged -0.75% as expected; Franc remains highly valued; prepared to intervene in FX markets; as necessary; 2021 GDP expected 3.5% vs. 2.5-3.0% previous Sector News Breakdown Consumer Lennar Corp. ($LEN) Q2 adj EPS $2.95 vs. est. 42.36; Q2 revs $6.4B vs. est. $5.91B; Deliveries of 14,493 homes, up 14%; new orders of 17,157 homes, up 32%; backlog of 24,741 homes, up 38% (backlog dollar value of $11.0 billion, up 56%); homebuilding net margins of $1.1 billion, compared to $655.1 million and gross margin on home sales of 26.1%, compared to 21.6% Honest Company ($HNST) 1Q adj EPS ($0.05) vs. est. ($0.06) on revs $81Mm vs. est. $79.3Mm; digital channel revenue increased 2% to $42.5 mln in q1 of 2021 compared to q1 of 2020 (downgraded to Neutral at Guggenheim) China’s market regulator has commenced an antitrust probe into Didi Chuxing as it prepares for a U.S. IPO, Reuters’ reported Energy, Industrials and Materials Northern Oil and Gas, Inc. ($NOG) announces core Permian basin bolt-on acquisitions of $102.2M; management intends to submit a request for a 50% increase to quarterly dividend; commenced underwritten public offering of 5 mln shares of its common stock Northern Oil and Gas ($NOG) 5M share Spot Secondary priced at $17.25 Culp Inc. ($CULP) Q4 adj EPS $0.11 on sales $79.1M vs. est. $0.08 and $66.1M; sees near-term headwinds temporarily pressuring business in FY22 The Federal Aviation Administration issued a directive for Boeing ($BA) requiring operators of 737 MAX airplanes to conduct additional inspections for the plane’s automated flight control system. The directive makes mandatory instructions released by Boeing in December that recommend that planes with more than 6,000 flight hours be subject to specific electronic checks. Financials The Justice Department said late Wednesday it would sue to stop insurance broker Aon’s ($AON) $30 billion bid for Willis Towers Watson ($WLTW) citing antitrust concerns. Shares of Arthur Gallagher ($AJG) shares fell – recall the co had agreed to buy assets from the two insurance brokers were selling in order to get antitrust approval in Europe Angel Oak Mortgage ($AOMR)2M share IPO priced at $19.00 The9 Limited ($NCTY) selects Coinbase Custody, a wholly owned subsidiary of Coinbase Global ($COIN) as the custodian for The9’s digital assets, including Bitcoin BNY Mellon ($BK) upgraded to Outperform from Market Perform at Keefe Bruyette Northern Trust ($NTRS) downgraded to Market Perform from Outperform at Keefe Bruyette Voya Financial ($VOYA) downgraded to Neutral from Buy at Citi Healthcare CureVac ($CVAC) shares fell 45% after saying its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study’s main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union. C4 Therapeutics ($CCCC)25M share Secondary priced at $37.00 iSpecimen ($ISPC)25M share IPO priced at $8.00 Biogen Inc. ($BIIB) announced topline results from its Phase 2 TANGO study of gosuranemab (BIIB092), an investigational anti-tau antibody that was being evaluated as a potential treatment for Alzheimer’s disease. Satsuma Pharmaceuticals ($STSA) announces positive pharmacokinetic, tolerability and safety results from phase 1 trial of sts101 at multiple dose strengths Tarsus Pharmaceuticals ($TARS) has initiated dosing participants in its first clinical trial for TP-05, a novel, oral, non-vaccine therapeutic for the prevention of Lyme disease. Lyell Immunopharma ($LYEL) 25M share IPO priced at $17.00 Verve Therapeutics ($VERV)04M share IPO priced at $19.00 Technology, Media & Telecom Baidu ($BIDU) is partnering with BAIC Group’s EV brand ARCFOX to jointly release Apollo Moon, a new generation of robotaxis that are set to be mass-produced with a per unit manufacturing price of RMB 480,000 Nokia ($NOK) to expedite rollout following the availability of a 3.5GHz spectrum; the improved services will offer premium 5G speeds to customers. Elbit Systems ($ESLT) subsidiary has been awarded two orders with an aggregate value of ~$29M by the US army’s program Urban One ($UONE) files to sell 2.93M shares of Class A common stock for holders

150 Replies 15 👍 9 🔥

profile
@viking #StockTraders.NET
recently

Upside: -NOVN +32% (reports positive topline results from pivotal Phase III trial of SB206 in patients with molluscum contagiosum) -PGEN +28% (announces positive topline results from Phase 1b/2a study of AG019 ActoBiotics, a Novel Therapy designed to address the underlying cause of Type 1 Diabetes; primary endpoints were met) -GENE +15% (US Patent Office grants foundational pharmacogenomic patent) -MX +15% (confirms 21% improved rival bid of $35/shr cash unsolicited proposal from Cornucopia Investment Partners) -ZDGE +9.5% (earnings, guidance) -ATC +8.4% (MKS Instruments said to have approached Atotech for acquisition) -ADMP +5.9% (provides update on clinical trial start-up progress for tempol in the treatment of COVID-19) -RFP +5.6% (announces $1/share Special Dividend, and $50M in lumber investments) -PLAY +5.3% (earnings, guidance) -AUTL +5.1% (presents new data on obe-cel in r/r Indolent B cell lymphomas and gives an update of obe-cel in r/r Adult ALL at the European Hematology Association Virtual Congress) -MBIO +5.0% (announced updated interim Phase 1/2 data for MB-106) -TYME +5.0% (comprehensive strategic review identified breast cancer as a priority indication for development, a focus on second-line pancreatic cancer, and continuation of trial in high-risk sarcomas) -LIFE +2.5% (presents poster demonstrating functional selectivity of second Anti-NRP2 Antibody) -OCGN +1.4% (Roth Capital broker downgrade) -AVO +1.3% (earnings, guidance) Downside: -ORPH -52% (application for MIPLYFFA under priority review with FDA, expected Prescription Drug User Fee Act action date of June 17; company not aware for reason for stock volatility) -VRTX -14% (reports primary endpoint achieved in Phase 2 Study of VX-864 in Alpha-1 Antitrypsin Deficiency but magnitude of treatment effect observed unlikely to translate into substantial clinical benefit) -CVAC -11% (downside momentum) -INCY -4.0% (FDA extendes the New Drug Application review period for ruxolitinib cream for the treatment of atopic dermatitis) -ADC -3.9% (prices 4.0M shares at implied $71.50/shr to raise $286M) -SNOW -3.7% (provides 2029 financial targets) -ELY -3.6% (to join S&P MidCap 400) -LTHM -3.2% (prices 13M shares at $17.50/shr) -AGNC -3.1% (reports tangible net book value) -RCL -2.1% (two guests aboard Celebrity Millennium test positive for COVID during required end-of-cruise testing) -CHWY -1.4% (earnings, guidance)

143 Replies 11 👍 7 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

/*============================================= = Friday, June 11, 2021 = =============================================*/ Futures Up/Down % Last Dow 75.00 0.22% 34,429 S&P 500 4.25 0.11% 4,233 Nasdaq 13.50 0.09% 13,963 Stock futures are looking higher, trying to build off yesterday’s gains as the S&P 500 Index posted its first closing high in over a month and as the Nasdaq Composite outperformed (rising over 0.75%) as the yield on the benchmark 10-year yield fell to its lowest levels since March, now down around the 1.43% level. Market fears of rising prices and inflation have deteriorated despite another spike in CPI yesterday when prices topped 5% on YoY basis, its highest levels since 2008 as investors hang on to the notion (implied by the Fed) that the price hikes are indeed transitory. Market gains were paced by strong gain in healthcare and REITs. In Asian markets, The Nikkei Index fell -9 points to 28,948, the Shanghai Index slid -21 points to 3,589, and the Hang Seng Index rose 103 points to 28,842. In Europe, the German DAX is up about 40 points to 15,610, while the FTSE 100 is higher by 45 points to 7,133. Market Closing Prices Yesterday The S&P 500 Index gained 19.63 points, or 0.47%, to 4,239.18 The Dow Jones Industrial Average rose 19.10 points, or 0.06%, to 34,466.24 The Nasdaq Composite jumped 108.58 points, or 0.78%, to 14,020.33 The Russell 2000 Index declined -15.72 points, or 0.68% to 2,311.41 Events Calendar for Today 10:00 AM EST University of Michigan Sentiment June-P 1:00 PM EST Baker Hughes Weekly rig count data Other Key Events: FBN Securities Silicon Valley Tech Tour (virtual), 6/10-6/11 Oppenheimer Virtual Software & Semiconductor Bus Tour, 6/7-6/11 Macro Up/Down Last Nymex 0.13 70.42 Brent 0.14 72.66 Gold -6.00 1,892.50 EUR/USD -0.0014 1.2156 JPY/USD 0.16 109.49 10-Year Note -0.021 1.437% World News The U.S. Senate Commerce Committee unveiled on Thursday a bipartisan surface transportation bill that would authorize $78 billion over five years, including sharply higher passenger rail funding, along with tougher auto safety requirements. Ten Senate Democrats and Republicans say they reached five-year, nearly $1 trillion infrastructure deal ‘; agreement calls for about $974 bln in infrastructure spending over five years without raising taxes. The package includes about $579 bln in new spending. UK Apr GDP beat m/m: 2.3% m/m vs 2.2% cons; 3m/3m 1.5% in-line; y/y 27.6% in-line; UK April Trade Balance smaller deficit: -£10.96b vs -£12.1b consensus; UK Apr Trade Balance non-EU smaller deficit: -£5.55b vs -£6.54b previous Sector News Breakdown Consumer Chewy ($CHWY) 1Q EPS $0.09 vs. est. ($0.03) on sales $2.14B vs. est. $2.13B; Gross margin of 27.6% expanded 420 bps YoY; net margin of 1.8% improved 480 bps YoY; Q1 adjusted EBITDA of $77.4M; Q1 active customers 19.8M, up 31.6% from last year Dave & Busters ($PLAY) Q1 EPS $0.40 vs. est. loss (-$0.19); Q1 revs $265.3M vs. est. $256.6M; Q1 comp store sales fell -35%; sees Q2 revs $335M-$350M vs. est. $287.4M Copa Holdings ($CPA) reports revenue passenger miles dropped 58% to 753.6M in May 2021 vs. May 2019; capacity down 53.4% to 970.9M available seat miles as compared to May 2019 Energy, Industrials and Materials The IEA forecasts global oil demand to recover to pre-pandemic levels late next year and urged OPEC and its allies to keep markets balanced by tapping their plentiful spare production capacity Livent ($LTHM) 13M share Secondary priced at $17.50 REV Group ($REVG)5M share Secondary priced at $15.50 Navigator Holdings ($NVGS) Q1 EPS $0.05 vs. est. $0.05; Q1 revs $85.7M vs. est. $71.29M Financials AGNC Investment ($AGNC) estimates tangible net book value per share of $16.82 as of May 31, 2021, down 6.4% from $17.96 it estimated at April 30. Agree Realty ($ADC) 4M share Spot Secondary priced at $71.50 Manning & Napier ($MN) reports preliminary AUM $22.1B as of May 31 Victory Capital Holdings, Inc. ($VCTR) reported assets under management (AUM) of $160.9 billion as of May 31, 2021 TaskUs ($TASK)2M share IPO priced at $23.00 Healthcare Vertex Pharma ($VRTX) shares declined over 10% after abandoning further development of VX-864 for alpha-1 antitrypsin deficiency saying that the treatment benefit seen in a phase 2 study is “unlikely to translate into substantial clinical benefit.” Jury selection began this week in a case considered one of the biggest and most complicated in the effort to hold corporations liable for the opioid crisis according to Barron’s. The trial, in New York, was delayed a year because of the pandemic. New York state and two of its counties, Nassau and Suffolk on Long Island, are suing a number of companies, including Johnson & Johnson (JNJ), McKesson ($MCK) and Teva Pharmaceutical ($TEVA), for monetary damages Tyme Technologies, Inc. ($TYME) completes strategic review, announces oasis breast trial with Georgetown University, and reports fiscal year 2021 financial results; review identified breast cancer as a priority indication for development, a focus on second-line pancreatic cancer, and continuation of trial in high-risk sarcomas CureVac ($CVAC) slides; The efficacy of CureVac’s Covid-19 vaccine is still hard to determine but is set to remain in focus as critical data from the phase 3 trial is expected this month, Berenberg says. Analysts at the bank say the trial’s progress seems encouraging and could facilitate a rapid regulatory discussion in the coming months. They expect the CVnCoV vaccine to be 70% to 80% effective – DJ PTC Therapeutics ($PTCT) announced interim results from the ongoing RAINBOWFISH trial that demonstrated pre-symptomatic infants with spinal muscular atrophy, or SMA Vertex Pharmaceuticals ($VRTX) and CRISPR Therapeutics ($CRSP) announce new data on 22 patients, with follow-up of at least 3 months, treated with CRISPR/Cas9-based gene-editing therapy, CTX001 Technology, Media & Telecom Nvidia ($NVDA) has agreed to acquire DeepMap, a startup committed to building high-definition maps for autonomous vehicles to navigate the world safely Didi Chuxing, China’s biggest ride-hailing firm, made public the filing for its long-anticipated U.S. stock market listing, setting the stage for what is expected to be the world’s biggest initial public offering this year. SeaChange ($SEAC) 1Q adj EPS ($0.07) vs. est. ($0.09) on revs $5.1Mm vs. est. $4.9Mm; qtr end backlog $20.1Mm

53 Replies 6 👍 14 🔥

profile
@Carlos-carvan58 #ivtrades
recently

strangle $CVAC 135/85 2,840 volume x side

103 Replies 7 👍 8 🔥

profile
@FUZZJP #ivtrades
recently

$CVAC on the watchlist, share lockup expires 2/9

64 Replies 6 👍 7 🔥

profile
@Carlos-carvan58 #ivtrades
recently

2,000 $CVAC 100 16 APR 21 180 CALL @11.80 LMT

137 Replies 14 👍 7 🔥

profile
@dros #droscrew
recently

looks like a player our here rolling CVAC

121 Replies 14 👍 14 🔥

profile
@Neptune5045 #StockTraders.NET
recently

$CVAC running again

135 Replies 7 👍 15 🔥

profile
@FillTheGapToZero #StockTraders.NET
recently

CVAC is just bleeding

113 Replies 14 👍 9 🔥

profile
@Chano #StockTraders.NET
recently

$CVAC currently $0.414

117 Replies 10 👍 12 🔥

profile
@FillTheGapToZero #StockTraders.NET
recently

CVAC I was hesitating to locate

102 Replies 9 👍 6 🔥

profile
@FillTheGapToZero #StockTraders.NET
recently

CVAC omg... those 80 cent locates looking like they were worth it..

141 Replies 10 👍 6 🔥

profile
@TraderXx #StockTraders.NET
recently

Slowly proving it > @TraderXx said: $CVAC I bet early stubborn shorts will get smoked on it

61 Replies 10 👍 9 🔥

profile
@FillTheGapToZero #StockTraders.NET
recently

CVAC locates pretty expensive... my broker is charging 84 cents 😭😭💀

57 Replies 10 👍 8 🔥

profile
@FillTheGapToZero #StockTraders.NET
recently

gonna wait for that 80 crack on CVAC before even contemplating to short it

81 Replies 15 👍 13 🔥

profile
@TraderXx #StockTraders.NET
recently

$CVAC I bet early stubborn shorts will get smoked on it

133 Replies 10 👍 7 🔥

profile
@Neptune5045 #StockTraders.NET
recently

$CVAC is a crazy IPO. 40s to 56 last friday and now it’s 92

93 Replies 8 👍 15 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

dang CVAC is going to the moon

59 Replies 9 👍 11 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

bought some lottery on CVAC

116 Replies 11 👍 13 🔥

Key Metrics

Market Cap

9.21 B

Beta

0

Avg. Volume

694.95 K

Shares Outstanding

186.91 M

Yield

0%

Public Float

0

Next Earnings Date

2021-08-20

Next Dividend Date

Company Information

CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.

Website:

HQ: Friedrich-Miescher-Str. 15 Tuebingen, 72076 Baden Wuerttemberg

Related News

  • Endpoints News

    In CureVac''s failure, a possible verdict on the past (and future) of mRNA vaccines

    28 Jul 2021, 10:58
  • Jumbo News

    mRNA Vaccine And Therapeutics Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Argos Therapeutics, BioNTech, CureVac, eTheRNA, Ethris, In-Cell-Art, Moderna Thera

    25 Jul 2021, 11:16
  • DirectorsTalk

    Novartis AG Consensus Indicates Potential 16.0% Upside

    23 Jul 2021, 12:27
  • Benzinga

    Worldwide RNA Therapeutics Industry - Featuring BioNTech, Moderna Therapeutics and CureVac Among Others

    15 Jul 2021, 14:45
  • Tramways Monthly

    mRNA Cancer Vaccines and Therapeutics Market to Witness Notable Growth by 2026 Covid-19 Analysis | Moderna Therapeutics, eTheRNA, BioNTech, CureVac, In-Cell-Art

    12 Jul 2021, 14:20